Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL4A3 HSPG2 COL6A2 COL6A3 VWF LAMA1 COL6A5 THBS4 MMRN2	6.65e-05	188	185	9	GO:0005201
GeneOntologyMolecularFunction	clathrin heavy chain binding	PLK2 DNAJC6 LRP1	1.62e-04	12	185	3	GO:0032050
GeneOntologyMolecularFunction	plus-end directed microfilament motor activity	MYO10 MYO19	2.55e-04	3	185	2	GO:0060002
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NADP+) activity	ME2 ME3	2.55e-04	3	185	2	GO:0004473
GeneOntologyMolecularFunction	apolipoprotein receptor activity	ABCA1 LRP1	2.55e-04	3	185	2	GO:0030226
GeneOntologyMolecularFunction	L-glutamate uniporter activity	SLC17A8 SLC17A7	2.55e-04	3	185	2	GO:0140788
GeneOntologyMolecularFunction	malic enzyme activity	ME2 ME3	5.06e-04	4	185	2	GO:0004470
GeneOntologyMolecularFunction	oxaloacetate decarboxylase activity	ME2 ME3	5.06e-04	4	185	2	GO:0008948
GeneOntologyMolecularFunction	histone H3K36me/H3K36me2 demethylase activity	KDM2B KDM2A	5.06e-04	4	185	2	GO:0140680
GeneOntologyMolecularFunction	apolipoprotein binding	ABCA1 LRP1 MTTP	7.94e-04	20	185	3	GO:0034185
GeneOntologyMolecularFunction	membrane potential driven uniporter activity	SLC17A8 SLC17A7	8.38e-04	5	185	2	GO:0022810
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL4A3 COL6A2 COL6A3 COL6A5	8.59e-04	46	185	4	GO:0030020
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 ASXL2 RPL11	9.20e-04	21	185	3	GO:0042975
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 GET4 NOMO2 NOMO3	5.91e-06	14	188	4	GO:0072379
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	5.78e-05	9	188	3	GO:0160064
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL4A3 HSPG2 COL6A2 COL6A3 VWF MMP28 ITLN1 CTSC LAMA1 COL6A5 LGALS3 TGM2 THBS4 MMRN2 EGFLAM	9.46e-05	530	188	15	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	COL4A3 HSPG2 COL6A2 COL6A3 VWF MMP28 ITLN1 CTSC LAMA1 COL6A5 HPSE LGALS3 TRIL TGM2 THBS4 MMRN2 EGFLAM	9.47e-05	656	188	17	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL4A3 HSPG2 COL6A2 COL6A3 VWF MMP28 ITLN1 CTSC LAMA1 COL6A5 HPSE LGALS3 TRIL TGM2 THBS4 MMRN2 EGFLAM	9.82e-05	658	188	17	GO:0030312
Domain	-	HSPG2 LAMA1 LGALS3 FAT1 THBS4 CELSR3 NRXN2 EGFLAM WDFY3	4.47e-07	95	186	9	2.60.120.200
Domain	CarboxyPept-like_regulatory	CPN1 NOMO1 TENM3 NOMO2 NOMO3	5.21e-07	17	186	5	IPR008969
Domain	VWA	COL6A2 COL6A3 CLCA4 VWF COL6A5 ITGAX CACNA2D3	1.33e-06	56	186	7	PF00092
Domain	Laminin_G	HSPG2 LAMA1 FAT1 THBS4 CELSR3 NRXN2 EGFLAM	1.70e-06	58	186	7	IPR001791
Domain	VWA	COL6A2 COL6A3 CLCA4 VWF COL6A5 VWA7 ITGAX CACNA2D3	1.90e-06	84	186	8	SM00327
Domain	LAM_G_DOMAIN	HSPG2 LAMA1 FAT1 CELSR3 NRXN2 EGFLAM	1.91e-06	38	186	6	PS50025
Domain	Laminin_G_2	HSPG2 LAMA1 FAT1 CELSR3 NRXN2 EGFLAM	2.61e-06	40	186	6	PF02210
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.86e-06	4	186	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.86e-06	4	186	3	IPR019008
Domain	LamG	HSPG2 LAMA1 FAT1 CELSR3 NRXN2 EGFLAM	4.64e-06	44	186	6	SM00282
Domain	EGF	HSPG2 DNER LRP1B FAT1 THBS4 CELSR3 NRXN2 LRP1 EGFLAM	4.80e-06	126	186	9	PF00008
Domain	CarboxyPept_regulatory_dom	CPN1 NOMO1 NOMO2 NOMO3	6.35e-06	13	186	4	IPR014766
Domain	-	CPN1 NOMO1 NOMO2 NOMO3	6.35e-06	13	186	4	2.60.40.1120
Domain	VWF_A	COL6A2 COL6A3 CLCA4 VWF COL6A5 VWA7 ITGAX CACNA2D3	6.58e-06	99	186	8	IPR002035
Domain	VWFA	COL6A2 COL6A3 CLCA4 VWF COL6A5 ITGAX CACNA2D3	1.76e-05	82	186	7	PS50234
Domain	EGF	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	2.45e-05	235	186	11	SM00181
Domain	EGF_CA	HSPG2 DNER LRP1B FAT1 THBS4 CELSR3 LRP1 EGFLAM	3.05e-05	122	186	8	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 DNER LRP1B FAT1 THBS4 CELSR3 LRP1 EGFLAM	3.42e-05	124	186	8	IPR001881
Domain	EGF-like_dom	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	4.17e-05	249	186	11	IPR000742
Domain	EGF_1	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	5.17e-05	255	186	11	PS00022
Domain	PH-BEACH_dom	WDFY4 LYST WDFY3	5.25e-05	8	186	3	IPR023362
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	5.25e-05	8	186	3	IPR013784
Domain	-	WDFY4 LYST WDFY3	5.25e-05	8	186	3	2.30.29.40
Domain	PH_BEACH	WDFY4 LYST WDFY3	5.25e-05	8	186	3	PS51783
Domain	EGF-like_CS	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	6.38e-05	261	186	11	IPR013032
Domain	ConA-like_dom	HSPG2 LAMA1 TRIM22 LGALS3 FAT1 THBS4 CELSR3 NRXN2 EGFLAM WDFY3	7.10e-05	219	186	10	IPR013320
Domain	EGF_2	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	7.31e-05	265	186	11	PS01186
Domain	BEACH	WDFY4 LYST WDFY3	7.81e-05	9	186	3	PS50197
Domain	Beach	WDFY4 LYST WDFY3	7.81e-05	9	186	3	PF02138
Domain	-	WDFY4 LYST WDFY3	7.81e-05	9	186	3	1.10.1540.10
Domain	Beach	WDFY4 LYST WDFY3	7.81e-05	9	186	3	SM01026
Domain	BEACH_dom	WDFY4 LYST WDFY3	7.81e-05	9	186	3	IPR000409
Domain	-	COL6A2 COL6A3 CLCA4 VWF COL6A5 CACNA2D3	9.51e-05	74	186	6	3.40.50.410
Domain	Vitellinogen_b-sht_N	APOB MTTP	9.86e-05	2	186	2	IPR015816
Domain	Lipid_transp_b-sht_shell	APOB MTTP	9.86e-05	2	186	2	IPR015819
Domain	-	APOB MTTP	9.86e-05	2	186	2	2.30.230.10
Domain	VITELLOGENIN	APOB MTTP	9.86e-05	2	186	2	PS51211
Domain	LPD_N	APOB MTTP	9.86e-05	2	186	2	SM00638
Domain	DUF5050	LRP1B LRP1	9.86e-05	2	186	2	IPR032485
Domain	Lipid_transpt_N	APOB MTTP	9.86e-05	2	186	2	IPR001747
Domain	-	APOB MTTP	9.86e-05	2	186	2	1.25.10.20
Domain	Vitellogenin_N	APOB MTTP	9.86e-05	2	186	2	PF01347
Domain	DUF5050	LRP1B LRP1	9.86e-05	2	186	2	PF16472
Domain	EGF_3	HSPG2 DNER LRP1B FAT1 THBS4 CELSR3 TENM3 NRXN2 LRP1 EGFLAM	1.27e-04	235	186	10	PS50026
Domain	Laminin_G_1	HSPG2 LAMA1 EGFLAM	1.51e-04	11	186	3	PF00054
Domain	Malic_OxRdtase	ME2 ME3	2.94e-04	3	186	2	IPR001891
Domain	Malic_NAD-bd	ME2 ME3	2.94e-04	3	186	2	IPR012302
Domain	Malic_N_dom	ME2 ME3	2.94e-04	3	186	2	IPR012301
Domain	MALIC_ENZYMES	ME2 ME3	2.94e-04	3	186	2	PS00331
Domain	Malic_M	ME2 ME3	2.94e-04	3	186	2	PF03949
Domain	Malic_M	ME2 ME3	2.94e-04	3	186	2	SM00919
Domain	malic	ME2 ME3	2.94e-04	3	186	2	PF00390
Domain	-	ME2 ME3	2.94e-04	3	186	2	3.40.50.10380
Domain	malic	ME2 ME3	2.94e-04	3	186	2	SM01274
Domain	Vitellinogen_superhlx	APOB MTTP	2.94e-04	3	186	2	IPR011030
Domain	Malic_enzyme_CS	ME2 ME3	2.94e-04	3	186	2	IPR015884
Domain	VPS13	VPS13C VPS13D	2.94e-04	3	186	2	IPR026847
Domain	VPS13_mid_rpt	VPS13C VPS13D	2.94e-04	3	186	2	PF16910
Domain	VPS13	VPS13C VPS13D	2.94e-04	3	186	2	PF16908
Domain	VPS13_N2	VPS13C VPS13D	2.94e-04	3	186	2	IPR031646
Domain	VPS13_mid_rpt	VPS13C VPS13D	2.94e-04	3	186	2	IPR031642
Domain	PHD_4	KDM2B KDM2A	2.94e-04	3	186	2	PF16866
Domain	LY	LRP1B LRP1 ROS1	4.05e-04	15	186	3	SM00135
Domain	LDLR_classB_rpt	LRP1B LRP1 ROS1	4.05e-04	15	186	3	IPR000033
Domain	-	PLK2 PLK5	5.84e-04	4	186	2	3.30.1120.30
Domain	SHR-BD	VPS13C VPS13D	5.84e-04	4	186	2	IPR009543
Domain	POLO_box_1	PLK2 PLK5	5.84e-04	4	186	2	IPR033701
Domain	VPS13_C	VPS13C VPS13D	5.84e-04	4	186	2	PF16909
Domain	VPS13_C	VPS13C VPS13D	5.84e-04	4	186	2	IPR031645
Domain	SHR-BD	VPS13C VPS13D	5.84e-04	4	186	2	PF06650
Domain	-	LRP1B TENM3 LRP1 ROS1	5.96e-04	39	186	4	2.120.10.30
Domain	ARM-type_fold	USP9X DOCK9 UBR4 APOB USP9Y WDFY4 LYST THADA CSE1L RRP12 WDFY3	6.10e-04	339	186	11	IPR016024
Domain	Leu-rich_rpt_Cys-con_subtyp	FBXL14 KDM2B KDM2A	8.37e-04	19	186	3	IPR006553
Domain	LRR_CC	FBXL14 KDM2B KDM2A	8.37e-04	19	186	3	SM00367
Domain	POLO_box_dom	PLK2 PLK5	9.67e-04	5	186	2	IPR000959
Domain	Growth_fac_rcpt_	HSPG2 LAMA1 DNER LRP1B FAT1 THBS4 LRP1	9.71e-04	156	186	7	IPR009030
Domain	6-blade_b-propeller_TolB-like	LRP1B TENM3 LRP1 ROS1	1.12e-03	46	186	4	IPR011042
Domain	LDLRA_1	HSPG2 LRP1B PKD1 LRP1	1.32e-03	48	186	4	PS01209
Domain	LDLRA_2	HSPG2 LRP1B PKD1 LRP1	1.42e-03	49	186	4	PS50068
Domain	PH_BEACH	LYST WDFY3	1.44e-03	6	186	2	PF14844
Domain	Spectrin	KALRN SPTBN5 SYNE3	1.49e-03	23	186	3	PF00435
Domain	FBOX	FBXW12 FBXL14 KDM2B KDM2A	1.78e-03	52	186	4	SM00256
Domain	Chorein_N	VPS13C VPS13D	2.66e-03	8	186	2	PF12624
Domain	VPS13_N	VPS13C VPS13D	2.66e-03	8	186	2	IPR026854
Domain	LAMININ_IVA	HSPG2 LAMA1	2.66e-03	8	186	2	PS51115
Domain	Laminin_B	HSPG2 LAMA1	2.66e-03	8	186	2	PF00052
Domain	LamB	HSPG2 LAMA1	2.66e-03	8	186	2	SM00281
Domain	Laminin_IV	HSPG2 LAMA1	2.66e-03	8	186	2	IPR000034
Domain	EGF_Ca-bd_CS	DNER LRP1B FAT1 THBS4 LRP1	2.86e-03	97	186	5	IPR018097
Domain	Spectrin_repeat	KALRN SPTBN5 SYNE3	2.93e-03	29	186	3	IPR002017
Domain	WD40_repeat_dom	UBR4 APAF1 WDFY4 LYST DDB1 SHKBP1 TENM3 WDFY3 WDR49	3.00e-03	297	186	9	IPR017986
Domain	EGF_CA	DNER LRP1B FAT1 THBS4 LRP1	3.12e-03	99	186	5	PS01187
Domain	EGF_LAM_2	HSPG2 LAMA1 CELSR3	3.24e-03	30	186	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA1 CELSR3	3.24e-03	30	186	3	PS01248
Domain	ASX_HYDROXYL	DNER LRP1B FAT1 CELSR3 LRP1	3.26e-03	100	186	5	PS00010
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL4A3 HSPG2 COL6A2 COL6A3 LAMA1 COL6A5 ITGAX	1.66e-05	76	151	7	M27219
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL4A3 HSPG2 COL6A2 COL6A3 VWF COL6A5 ITGAX	3.45e-05	85	151	7	M16441
Pathway	REACTOME_MIRO_GTPASE_CYCLE	MYO19 RHOT2 MFN1	4.09e-05	7	151	3	MM15689
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL4A3 COL6A2 COL6A3 COL6A5 SPTBN5	4.98e-05	38	151	5	MM14969
Pathway	REACTOME_NCAM1_INTERACTIONS	COL4A3 COL6A2 COL6A3 COL6A5	5.36e-05	20	151	4	MM15061
Pathway	REACTOME_MIRO_GTPASE_CYCLE	MYO19 RHOT2 MFN1	6.49e-05	8	151	3	M41837
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL4A3 COL6A2 COL6A3 VWF COL6A5 ITGAX	1.61e-04	76	151	6	MM14867
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	HSPG2 COL6A2 COL6A3 VWF LAMA1 THBS4	2.79e-04	84	151	6	M7098
Pathway	WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION	ABCA1 APOB LRP1 MTTP	3.18e-04	31	151	4	M39514
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A3 COL6A2 COL6A3 COL6A5 THBS4	3.53e-04	57	151	5	MM14713
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A3 COL6A2 COL6A3 COL6A5 THBS4	3.83e-04	58	151	5	M2049
Pubmed	High-throughput microarray detection of olfactory receptor gene expression in the mouse.	OR2M7 OR2M2 OR2M5 OR2M3	8.63e-10	4	190	4	15377787
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HSPG2 COL6A2 COL6A3 VWF ITLN1 LAMA1 COL6A5 LGALS3 TGM2 THBS4 MMRN2	2.33e-09	167	190	11	22159717
Pubmed	Functional proteomics mapping of a human signaling pathway.	HSPG2 VWF UBR4 FNBP4 RHOT2 PIAS1 DDB1 NOMO1 TGM2 ZFYVE9 TENM3 RBM19 PKD1 LRP1 KDM2A ASXL2 NOMO3 KNL1	5.13e-09	591	190	18	15231748
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 KALRN MYO10 DOCK9 UBR4 FBXL14 RHOT2 LYST KIAA2013 KCNH3 MST1R FAT1 THADA C2CD3 GET4 SYNE3 RPAP1 CELSR3 SYNJ1 TRAPPC12 RBM19 RRP12 PKD1 WDFY3	1.00e-08	1105	190	24	35748872
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	GPI HSPG2 COL6A3 VWF KALRN ITLN1 VPS13C CTSC APAF1 RRAS DDB1 DDC LGALS3 TGM2 VPS13D FAT1 PTPN13 CSE1L ATP6V0A4 PKD1 MMRN2 C5	4.58e-08	1016	190	22	19056867
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL4A3 HSPG2 COL6A2 COL6A3 VWF COL6A5 LGALS3 TGM2 MMRN2	6.20e-08	135	190	9	28675934
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	1.60e-07	3	190	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	1.60e-07	3	190	3	25576386
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL4A3 HSPG2 COL6A2 COL6A3 VWF CTSC LAMA1 COL6A5 TGM2	5.66e-07	175	190	9	28071719
Pubmed	Replicative verification of susceptibility genes previously identified from families with segregating developmental dysplasia of the hip.	HSPG2 PTGFR TENM3	6.39e-07	4	190	3	34174923
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	6.39e-07	4	190	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	6.39e-07	4	190	3	9267806
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 TNFSF9 CTSC LAMA1 DNER LRP1B DDB1 PTGFRN KIAA2013 NOMO1 MST1R TGM2 FAT1 THADA SERPINI1 CELSR3 TENM3 NOMO2 RRP12 LRP1 TXNDC16 SLC39A14	7.86e-07	1201	190	22	35696571
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	HSPG2 COL6A2 COL6A3 LAMA1 COL6A5 APOB	1.42e-06	64	190	6	22261194
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	HSPG2 COL6A2 COL6A3 LAMA1	1.49e-06	16	190	4	16880404
Pubmed	Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ.	HSPG2 VWF HPSE	1.59e-06	5	190	3	20684947
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A2 COL6A3 COL6A5	1.59e-06	5	190	3	23869615
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	REC114 VPS13C DNER PTGFR LRP1B RAB3C TENM3 ALDH1L2 CSMD1	1.65e-06	199	190	9	23382691
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO10 DOCK9 FAM91A1 DNAJC6 TRIL RPAP1 TENM3 RRP12 ASXL2 SLC39A14 BAIAP3 SEZ6L	2.80e-06	407	190	12	12693553
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	GPI USP9X CTSC UBR4 DDB1 NOMO1 CSE1L NOMO2 LACC1 NNT NOMO3	3.41e-06	344	190	11	30333137
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A2 COL6A3 COL6A5	5.53e-06	7	190	3	18276594
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A2 COL6A3 COL6A5	5.53e-06	7	190	3	18400749
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GPI COL4A3 CCDC30 VPS13C NELFB FAM91A1 APOB RAB3C FAT1 THADA PTPN13 TENM3 RBM19 SLC39A14 TASOR RPL11	6.48e-06	777	190	16	35844135
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	ACADSB VPS13C MYO19 MRPL37 UBR4 RHOT2 ME2 DDB1 MFN1 SPTBN5 VPS13D THADA GET4 OXCT1 RPAP1 ALDH1L2 RRP12 FUNDC2 AK4 SLC39A14 MTO1 NUDC NNT	8.08e-06	1496	190	23	32877691
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	8.81e-06	8	190	3	15257293
Pubmed	Genomic analysis of mouse retinal development.	PLK5 DDO RHOT2 PIAS1 CYP46A1 DDC TRIP4 NOMO1 GET4 SERPINI1 NRXN2 NOMO2 PKD1 SLC17A7 ETNK1 WDFY3 RIOK2 NOMO3	1.15e-05	1006	190	18	15226823
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA3 ACADSB USP9X MRPL37 UBR4 DDX51 RHOT2 PIAS1 TRAPPC12 KDM2B C5 WDFY3 NOMO3 KNL1	1.24e-05	638	190	14	31182584
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PLK2 UAP1 USP9X CPN1 PLA2G4E LRP1B PIAS1 KCNH3 SGK3 TGM2 ATP8A1 LRP1 PRKCG KDM2A MAPK6	1.30e-05	730	190	15	34857952
Pubmed	Differential interactions of cerebellin precursor protein (Cbln) subtypes and neurexin variants for synapse formation of cortical neurons.	NRXN2 CBLN2 SLC17A7	1.32e-05	9	190	3	21356198
Pubmed	Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A.	COL4A3 LAMA1 SAA1	1.32e-05	9	190	3	8995276
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	1.32e-05	9	190	3	36261522
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	HSPG2 COL6A2 COL6A3 VWF MMP28 APOB LGALS3	1.66e-05	146	190	7	27068509
Pubmed	Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.	COL6A3 PLK2 TRIL PHYH THBS4 LACC1	1.70e-05	98	190	6	19834535
Pubmed	Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.	COL4A3 HSPG2 LAMA1	1.87e-05	10	190	3	9136074
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	LAMA1 WDFY4 ATP8A1 RBM19 CSMD1 CACNA2D3	2.02e-05	101	190	6	18519826
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL4A3 HSPG2 COL6A2 COL6A3 VWF LGALS3 TGM2	2.25e-05	153	190	7	25037231
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	VPS13C UBR4 PTGFRN DNAH1 RPAP1 TXNDC16 CC2D2A	2.25e-05	153	190	7	10718198
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	NOMO1 NOMO2 NOMO3 RPL11	2.42e-05	31	190	4	19136429
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	2.56e-05	11	190	3	32820719
Pubmed	Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII.	VWF F8	2.97e-05	2	190	2	15731176
Pubmed	Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival.	HPSE LGALS3	2.97e-05	2	190	2	21153652
Pubmed	Striking differences of LDL receptor-related protein 1B expression in mouse and human.	LRP1B LRP1	2.97e-05	2	190	2	15963947
Pubmed	A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.	VWF F8	2.97e-05	2	190	2	38320121
Pubmed	Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.	VWF F8	2.97e-05	2	190	2	33221577
Pubmed	Mechano-covalent protection of coagulation factor VIII by von Willebrand factor.	VWF F8	2.97e-05	2	190	2	36240294
Pubmed	Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.	VWF F8	2.97e-05	2	190	2	19110358
Pubmed	Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.	VWF F8	2.97e-05	2	190	2	23690449
Pubmed	Human placenta secretes apolipoprotein B-100-containing lipoproteins.	APOB MTTP	2.97e-05	2	190	2	15504742
Pubmed	Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.	VWF F8	2.97e-05	2	190	2	22219226
Pubmed	von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.	VWF F8	2.97e-05	2	190	2	26635035
Pubmed	Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.	KDM2B KDM2A	2.97e-05	2	190	2	32901907
Pubmed	Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.	LGALS3 LRP1	2.97e-05	2	190	2	36880731
Pubmed	The role of VWF in the immunogenicity of FVIII.	VWF F8	2.97e-05	2	190	2	18549909
Pubmed	The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.	VWF F8	2.97e-05	2	190	2	9218428
Pubmed	The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.	VWF F8	2.97e-05	2	190	2	7756647
Pubmed	Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.	VWF F8	2.97e-05	2	190	2	18535282
Pubmed	Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus.	VWF F8	2.97e-05	2	190	2	20624989
Pubmed	Evidence That Factor VIII Forms a Bivalent Complex with the Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1): IDENTIFICATION OF CLUSTER IV ON LRP1 AS THE MAJOR BINDING SITE.	F8 LRP1	2.97e-05	2	190	2	27794518
Pubmed	Association of the factor VIII light chain with von Willebrand factor.	VWF F8	2.97e-05	2	190	2	3134349
Pubmed	The influence of von Willebrand factor on factor VIII activity measurements.	VWF F8	2.97e-05	2	190	2	18983499
Pubmed	Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.	VWF F8	2.97e-05	2	190	2	14517489
Pubmed	A common polymorphism decreases LRP1 mRNA stability and is associated with increased plasma factor VIII levels.	F8 LRP1	2.97e-05	2	190	2	28431990
Pubmed	Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain.	F8 LRP1	2.97e-05	2	190	2	16839343
Pubmed	Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues.	F8 LRP1	2.97e-05	2	190	2	25903134
Pubmed	Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities.	VWF F8	2.97e-05	2	190	2	15471879
Pubmed	The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.	NCOA3 PIAS1	2.97e-05	2	190	2	22283414
Pubmed	Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.	ABCA1 APOB	2.97e-05	2	190	2	28694219
Pubmed	The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.	VWF F8	2.97e-05	2	190	2	8562925
Pubmed	Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells.	APOB MTTP	2.97e-05	2	190	2	15795421
Pubmed	[Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease].	ABCA1 CYP46A1	2.97e-05	2	190	2	17550732
Pubmed	von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.	VWF F8	2.97e-05	2	190	2	20492463
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	2.97e-05	2	190	2	12895410
Pubmed	Solution structure of the major factor VIII binding region on von Willebrand factor.	VWF F8	2.97e-05	2	190	2	24700780
Pubmed	Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.	ABCA1 CYP46A1	2.97e-05	2	190	2	17335784
Pubmed	A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.	APOB MTTP	2.97e-05	2	190	2	10713055
Pubmed	Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.	VWF F8	2.97e-05	2	190	2	21940821
Pubmed	Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.	VWF F8	2.97e-05	2	190	2	26473492
Pubmed	ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.	NCOA3 MAPK6	2.97e-05	2	190	2	22505454
Pubmed	Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment.	VWF F8	2.97e-05	2	190	2	20194895
Pubmed	VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.	VWF F8	2.97e-05	2	190	2	23349392
Pubmed	Mitochondrial malic enzyme (E.C.1.1.1.40) in human leukocytes: formal genetics and population genetics.	ME2 ME3	2.97e-05	2	190	2	511162
Pubmed	Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.	APOB MTTP	2.97e-05	2	190	2	24842304
Pubmed	Interaction between VWF and FVIII in treating VWD.	VWF F8	2.97e-05	2	190	2	25605439
Pubmed	von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.	VWF F8	2.97e-05	2	190	2	37756521
Pubmed	Roles of phytanoyl-CoA alpha-hydroxylase in mediating the expression of human coagulation factor VIII.	F8 PHYH	2.97e-05	2	190	2	11574539
Pubmed	Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells.	APOB MTTP	2.97e-05	2	190	2	11358959
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	2.97e-05	2	190	2	8922996
Pubmed	Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies.	VWF F8	2.97e-05	2	190	2	17958741
Pubmed	Von Willebrand factor processing.	VWF F8	2.97e-05	2	190	2	28139814
Pubmed	Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.	VWF F8	2.97e-05	2	190	2	32032127
Pubmed	Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.	VWF F8	2.97e-05	2	190	2	12958606
Pubmed	Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.	VWF F8	2.97e-05	2	190	2	37720212
Pubmed	Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.	VWF F8	2.97e-05	2	190	2	23168412
Pubmed	Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation.	F8 LRP1	2.97e-05	2	190	2	18166789
Pubmed	Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.	VWF F8	2.97e-05	2	190	2	32189311
Pubmed	Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.	VWF F8	2.97e-05	2	190	2	32544272
Pubmed	Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions.	VWF F8	2.97e-05	2	190	2	15459008
Pubmed	Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.	APOB MTTP	2.97e-05	2	190	2	27487388
Pubmed	Cluster III of low-density lipoprotein receptor-related protein 1 binds activated blood coagulation factor VIII.	F8 LRP1	2.97e-05	2	190	2	25486042
Pubmed	Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.	APOB MTTP	2.97e-05	2	190	2	19056372
Cytoband	Ensembl 112 genes in cytogenetic band chr15q15	EXD1 PLA2G4E SPTBN5 TMEM62 RPAP1 KNL1	3.62e-05	147	190	6	chr15q15
Cytoband	1q44	OR2M7 OR2M2 OR2G2 OR2M5 OR2M3	9.92e-05	110	190	5	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2M7 OR2M2 OR2G2 OR2M5 OR2M3	2.02e-04	128	190	5	chr1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	HSPG2 PADI4 GALE UBR4 ASAP3 PLEKHN1 KIAA2013 VPS13D NUDC RPL11	5.91e-04	681	190	10	chr1p36
Cytoband	15q21	SPTBN5 MAPK6	9.14e-04	11	190	2	15q21
Cytoband	4q21.3	HPSE PTPN13	9.14e-04	11	190	2	4q21.3
Cytoband	15q15.1	EXD1 PLA2G4E RPAP1	9.89e-04	47	190	3	15q15.1
Cytoband	4q21.23	ABRAXAS1 WDFY3	1.29e-03	13	190	2	4q21.23
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 LYST WDFY3	2.89e-05	9	129	3	1230
GeneFamily	Collagens	COL4A3 COL6A2 COL6A3 COL6A5	3.20e-04	46	129	4	490
GeneFamily	F-box and leucine rich repeat proteins	FBXL14 KDM2B KDM2A	4.30e-04	21	129	3	558
GeneFamily	Cation channels sperm associated	CATSPERD CATSPERB	1.04e-03	7	129	2	186
GeneFamily	Olfactory receptors, family 2	OR2M7 OR2M2 OR2G2 OR2M5 OR2M3	1.30e-03	113	129	5	149
Coexpression	NABA_BASEMENT_MEMBRANES	COL4A3 HSPG2 COL6A2 COL6A3 LAMA1 COL6A5	3.82e-07	40	187	6	M5887
Coexpression	NABA_CORE_MATRISOME	COL4A3 HSPG2 COL6A2 COL6A3 VWF LAMA1 COL6A5 VWA7 THBS4 MMRN2 EGFLAM	4.15e-06	270	187	11	MM17057
Coexpression	NABA_CORE_MATRISOME	COL4A3 HSPG2 COL6A2 COL6A3 VWF LAMA1 COL6A5 VWA7 THBS4 MMRN2 EGFLAM	4.94e-06	275	187	11	M5884
Coexpression	SIRNA_EIF4GI_UP	CTSC SAA1 THADA PTPN13 CSE1L MTO1 ZBED1	5.47e-06	95	187	7	M2847
Coexpression	GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP	USP43 ARHGAP30 PIAS1 LYST SGK3 SERPINI1 ATP8A1 ETNK1 SLITRK6	1.39e-05	199	187	9	M9480
Coexpression	GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN	SLC9A9 VWF MYO19 FAM91A1 PLEKHN1 NOMO1 OXCT1 TXNDC16 WDFY3	1.44e-05	200	187	9	M9382
Coexpression	NABA_MATRISOME	COL4A3 HSPG2 COL6A2 COL6A3 VWF TNFSF9 MMP28 ITLN1 CTSC LAMA1 COL6A5 VWA7 HPSE LGALS3 TGM2 THBS4 SERPINI1 CBLN2 MMRN2 EGFLAM	3.76e-05	1008	187	20	MM17056
Coexpression	NABA_MATRISOME	COL4A3 HSPG2 COL6A2 COL6A3 VWF TNFSF9 MMP28 ITLN1 CTSC LAMA1 COL6A5 VWA7 HPSE LGALS3 TGM2 THBS4 SERPINI1 CBLN2 MMRN2 EGFLAM	4.80e-05	1026	187	20	M5889
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	PLK2 VWF CTSC HPSE ITGAX F8 LGALS3 KRT80 TGM2 ZFYVE9 LACC1 LRP1 MMRN2 WDFY3	1.58e-05	411	185	14	GSM538239_500
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 PLK2 VWF KALRN MMP28 CTSC LRP1B LYST RAB3C ME3 TGM2	5.12e-10	186	190	11	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF KALRN MMP28 DOCK9 ASAP3 LRP1B RAB3C ME3 MMRN2	1.08e-08	192	190	10	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL6A2 COL6A3 SLC9A9 KALRN MYO10 CTSC PTPN13 GUCY1A2 SLITRK6	1.17e-07	187	190	9	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A2 COL6A3 ABCA1 MYO10 LAMA1 COL6A5 TGM2 TENM3 LRP1	1.99e-07	199	190	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 PLK2 VWF MYO10 MMP28 DOCK9 CHST1 MMRN2 LRRC36	1.99e-07	199	190	9	63c01e8961f48ed1bed4ab619cacf318cd6de7b9
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C USP9Y HPSE LGALS3 KRT80 SGK3 LRP1 ICA1L	7.13e-07	170	190	8	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C USP9Y HPSE LGALS3 KRT80 SGK3 LRP1 ICA1L	7.13e-07	170	190	8	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	NCOA3 KALRN LYST MFN1 CSE1L NOMO2 TXNDC16 SLC39A14	9.26e-07	176	190	8	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCOA3 HSPG2 VWF F8 TGM2 MMRN2 SLC39A14 CSMD1	1.05e-06	179	190	8	d2db9e70b780643f1e004c41a70464d0abe26088
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 COL6A2 COL6A3 VWF F8 THBS4 GUCY1A2 EGFLAM	1.19e-06	182	190	8	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN LAMA1 APOB LRP1B DNAH1 FAT1 ROS1 CSMD1	1.29e-06	184	190	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN LAMA1 APOB LRP1B DNAH1 FAT1 ROS1 CSMD1	1.29e-06	184	190	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN LAMA1 APOB LRP1B DNAH1 FAT1 ROS1 CSMD1	1.29e-06	184	190	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	COL4A3 TRABD2B LAMA1 DNER LRP1B ME3 ATP6V0A4 CACNA2D3	1.52e-06	188	190	8	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 COL6A3 THBS4 GUCY1A2 CC2D2A SLITRK6 CSMD1 PDZD4	1.52e-06	188	190	8	0e2d1b21f0a7ee306e7dae16fc8c19d16a467883
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 VWF DOCK9 F8 RAB3C TGM2 MMRN2 CSMD1	1.58e-06	189	190	8	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 LAMA1 DNER USP43 ME3 ATP8A1 ATP6V0A4 CACNA2D3	1.58e-06	189	190	8	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A3 SLC9A9 MYO10 COL6A5 PTPN13 GUCY1A2 LRP1	1.58e-06	189	190	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 LAMA1 DNER USP43 ME3 ATP8A1 ATP6V0A4 CACNA2D3	1.64e-06	190	190	8	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	NCOA3 VPS13C LYST SYNE3 ATP8A1 NOMO2 ETNK1 EDRF1	1.71e-06	191	190	8	9454f642c3621370fa23640b631301346b300950
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF KALRN DOCK9 ASAP3 LRP1B RAB3C ME3	1.78e-06	192	190	8	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 VWF KALRN MMP28 ASAP3 RAB3C ME3 MMRN2	1.78e-06	192	190	8	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	LA\|World / Chamber and Cluster_Paper	COL6A2 SLC9A9 UAP1 ITLN1 PTGFR LRP1B SAA1 LRP1	1.85e-06	193	190	8	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYO10 IAPP USP9X VPS13C DDB1 DDC SEZ6L	2.00e-06	195	190	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL6A2 COL6A3 SLC9A9 MYO10 CTSC TRIL FAT1 GUCY1A2	2.00e-06	195	190	8	c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A2 COL6A3 TRABD2B ACADSB TRIL TGM2 LRP1 EGFLAM	2.07e-06	196	190	8	97e26622d9582b092c18ff5b7e957818f99d9631
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A2 COL6A3 TRABD2B ACADSB TRIL TGM2 LRP1 EGFLAM	2.07e-06	196	190	8	db64ab27374f82553ee577aec056141170f3656f
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 COL6A5 FAT1 TENM3 NRXN2 LRP1 CSMD1	2.07e-06	196	190	8	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 COL6A5 FAT1 TENM3 NRXN2 LRP1 CSMD1	2.07e-06	196	190	8	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 COL6A2 COL6A3 UAP1 TNFSF9 TENM3 LRP1 MAPK6	2.07e-06	196	190	8	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A2 COL6A3 TRABD2B ACADSB TRIL TGM2 LRP1 EGFLAM	2.07e-06	196	190	8	617103f4a09e009fe96c28eb5e40505a4fd6dcf4
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A2 COL6A3 TRABD2B ACADSB TRIL TGM2 LRP1 EGFLAM	2.07e-06	196	190	8	f429f045ba45e24717963315832150b12a115bfa
ToppCell	(08)_PNEC\|World / shred by cell type and Timepoint	VWF IAPP DNER DNAJC6 DDC RAB3C KCNH3 ATP8A1	2.07e-06	196	190	8	2ee37155c03cd5009427a4bffe6c80ed2ac6939e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 TRABD2B CCDC30 LAMA1 FAT1 PTPN13 ATP6V0A4 CACNA2D3	2.07e-06	196	190	8	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A2 COL6A3 UAP1 TNFSF9 TENM3 LRP1 MAPK6	2.07e-06	196	190	8	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOA3 HSPG2 PLK2 MYO10 VWA7 F8 NRXN2 MMRN2	2.15e-06	197	190	8	d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A2 COL6A3 ABCA1 MYO10 COL6A5 TENM3 LRP1 SLC39A14	2.15e-06	197	190	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOA3 HSPG2 PLK2 MYO10 VWA7 F8 NRXN2 MMRN2	2.15e-06	197	190	8	412091994196a06c2779b4c2cfed84be889a5f8d
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 VWF MMP28 DOCK9 CHST1 TGM2 MMRN2 LRRC36	2.15e-06	197	190	8	9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d
ToppCell	distal-Endothelial-Artery\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 PLK2 VWF MMP28 DOCK9 F8 TGM2 MMRN2	2.32e-06	199	190	8	b6e9aaac047d4b64b9d97f5e174e89a424d8b36d
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPI COL6A2 LGALS3 TGM2 SAA1 PKD1 AK4 SLC39A14	2.32e-06	199	190	8	e09bd3153dd60d06584707b259c78375b47415c8
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A2 COL6A3 SLC9A9 MYO10 COL6A5 TGM2 LRP1 SLITRK6	2.32e-06	199	190	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 VWF MMP28 DOCK9 CHST1 SPTBN5 MMRN2 LRRC36	2.32e-06	199	190	8	d95d78b2ebc9a20532466e4d4be579b4faf6776f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 VWF MMP28 DOCK9 CHST1 SPTBN5 MMRN2 LRRC36	2.32e-06	199	190	8	cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec
ToppCell	mild-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLK2 APAF1 ITGAX WDFY4 LRP1B CD1E CACNA2D3 SEZ6L	2.41e-06	200	190	8	86f585bf9066b179bbcbc703bf43f15da4a07284
ToppCell	cellseq2-Endothelial\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 HSPG2 VWF MMP28 DOCK9 F8 RAB3C MMRN2	2.41e-06	200	190	8	81bdf7a1ddc3e82b96526449e662cca26d7297b1
ToppCell	cellseq2-Endothelial-Endothelial_Vascular\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 HSPG2 VWF MMP28 DOCK9 F8 RAB3C MMRN2	2.41e-06	200	190	8	dc244a5ccec1b793dc4371fb2cd2c3fd4226283e
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A2 COL6A3 SLC9A9 ABCA1 MYO10 LAMA1 COL6A5 LRP1	2.41e-06	200	190	8	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	HSPG2 PLK2 VWF MMP28 ASAP3 LRP1B LYST TGM2	2.41e-06	200	190	8	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYO10 MMP28 LAMA1 DNER LGALS3 FAT1 AK4 SEZ6L	2.41e-06	200	190	8	46f99bed98da09e6d3f45d4443cbaa6b6c1589bb
ToppCell	COVID-19-COVID-19_Convalescent-Myeloid-cDC\|COVID-19_Convalescent / Disease, condition lineage and cell class	PLK2 ITGAX WDFY4 LGALS3 CD1E WDR49 CACNA2D3 SEZ6L	2.41e-06	200	190	8	ac9d7927863348a752444d2e80269a5eead943b7
ToppCell	mild-cDC\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLK2 APAF1 ITGAX WDFY4 LRP1B CD1E CACNA2D3 SEZ6L	2.41e-06	200	190	8	d6409ee5b9067be3dd2f852825e09151b5b22d7c
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKRD29 HSPG2 VWF MMP28 DOCK9 F8 RAB3C MMRN2	2.41e-06	200	190	8	0afc7a0f87eac48f772759c3b626758089733361
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITLN1 CHST1 DDC RAB3C SLC35F4 CELSR3 ADGRF4	2.64e-06	142	190	7	819e983688d126d89a71abc03d72525cc759a347
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	CLCA4 MMP28 DOCK9 VPS13D LRP1 MAPK6 ALOX12B	4.91e-06	156	190	7	ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0
ToppCell	facs-Marrow-B-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSC DNER RRAS PIGZ LGALS3 TENM3 LRP1	5.12e-06	157	190	7	0966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCell	facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSC DNER RRAS PIGZ LGALS3 TENM3 LRP1	5.12e-06	157	190	7	6ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell	BAL-Mild-cDC_0\|Mild / Compartment, Disease Groups and Clusters	ABCA1 CCDC30 MYO10 EBLN2 FAM91A1 TGM2 SYNE3	6.55e-06	163	190	7	7047d3ba847930f42a6d5f71e18d49f3071c6409
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 VPS13C RAB3C TG CELSR3 LACC1 PDZD4	7.98e-06	168	190	7	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	droplet-Fat-Bat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 VPS13C RAB3C TG CELSR3 LACC1 PDZD4	7.98e-06	168	190	7	794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCell	droplet-Fat-Bat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 VPS13C RAB3C TG CELSR3 LACC1 PDZD4	7.98e-06	168	190	7	1e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HSPG2 VWF DOCK9 PTGFR SERPINI1 MMRN2 SLC39A14	9.31e-06	172	190	7	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 VWF MMP28 DOCK9 RAB3C TG MMRN2	1.00e-05	174	190	7	6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d
ToppCell	368C-Endothelial_cells-Endothelial-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 PLK2 VWF CHST1 F8 TGM2 MMRN2	1.04e-05	175	190	7	c4088b5f9fa145869cf5dd8bee7680b1c8fada42
ToppCell	368C-Endothelial_cells-Endothelial-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 PLK2 VWF CHST1 F8 TGM2 MMRN2	1.04e-05	175	190	7	ca0d3e3a0a271cccdd3881b055fecb626712478d
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	NCOA3 KALRN LYST MFN1 CSE1L TXNDC16 SLC39A14	1.12e-05	177	190	7	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL4A3 DDO FAT1 TENM3 MMRN2 EGFLAM RNF180	1.16e-05	178	190	7	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HSPG2 VWF MMP28 TGM2 NOMO2 CBLN2 MMRN2	1.21e-05	179	190	7	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	(05)_Ciliated-(4)_1wkpi\|(05)_Ciliated / shred by cell type and Timepoint	EXD1 ITLN1 LGALS3 TGM2 RPAP1 ETNK1 KNL1	1.25e-05	180	190	7	85fc9b164147b28545e2397d32302eea03ef6346
ToppCell	droplet-Limb_Muscle-nan-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A2 COL6A3 LGALS3 THBS4 LRP1 SLC39A14	1.25e-05	180	190	7	d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACADSB MYO10 OXCT1 ZNF566 ETNK1 ADGRF4 ALOX12B	1.25e-05	180	190	7	0b653b1b653b40f3b8711d1312029a4a8a4961db
ToppCell	Neuroendocrine-neuroendo-1\|World / Class top	VWF IAPP DNER DDC RAB3C TG SERPINI1	1.25e-05	180	190	7	50fdd182a083380899b5943cb5f55ffd77e2a7d4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 IAPP LAMA1 SLCO1B1 PTGFR SLC35F4 CACNA2D3	1.30e-05	181	190	7	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 IAPP LAMA1 SLCO1B1 PTGFR SLC35F4 CACNA2D3	1.34e-05	182	190	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 UAP1 TRIL THBS4 LRP1 SLC39A14	1.34e-05	182	190	7	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GALE CTSC PTPN13 ATP8A1 ROS1 C5 CACNA2D3	1.34e-05	182	190	7	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF KALRN DOCK9 F8 RAB3C TGM2 MMRN2	1.39e-05	183	190	7	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLK2 VWF MMP28 DOCK9 TGM2 MMRN2 ALOX12B	1.39e-05	183	190	7	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	HSPG2 VWF DOCK9 F8 TGM2 MMRN2 CSMD1	1.44e-05	184	190	7	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTSC PTPN13 ATP8A1 ATP6V0A4 ROS1 C5 CACNA2D3	1.44e-05	184	190	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTSC LGALS3 PTPN13 ATP8A1 ATP6V0A4 C5 CACNA2D3	1.49e-05	185	190	7	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KALRN USP43 KCNH3 GUCY1A2 CBLN2 SLC17A7 DNAH6	1.55e-05	186	190	7	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ITGAX WDFY4 PTGFRN CD1E LACC1 CACNA2D3 SEZ6L	1.55e-05	186	190	7	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ITGAX WDFY4 PTGFRN CD1E LACC1 CACNA2D3 SEZ6L	1.55e-05	186	190	7	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HSPG2 VWF MMP28 DOCK9 CHST1 MMRN2 LRRC36	1.60e-05	187	190	7	29b2e2be26a9d72b154760e47acf61cfe2f45fa7
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL6A2 COL6A3 TRABD2B ACADSB TRIL LRP1 EGFLAM	1.66e-05	188	190	7	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Endothelial-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	SLC9A9 VWF KALRN DNAJC6 F8 RAB3C SLC39A14	1.66e-05	188	190	7	ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a
ToppCell	COVID-19-kidney-DCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A3 TRABD2B LAMA1 DNER LRP1B ATP6V0A4 CACNA2D3	1.66e-05	188	190	7	1d56cd409793f05cca20757ab26e91f1a1ee67b5
ToppCell	facs-Tongue-nan-24m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B PLA2G4E PLEKHN1 LGALS3 KRT80 ATP6V0A4 ALOX12B	1.66e-05	188	190	7	ed35e438796cef302b6787c111753425922792dc
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD29 COL4A3 CTSC PTPN13 ATP8A1 C5 CACNA2D3	1.66e-05	188	190	7	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 TRABD2B LAMA1 DNER ME3 ATP6V0A4 CACNA2D3	1.66e-05	188	190	7	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 PTGFRN THADA LRP1 EGFLAM CSMD1	1.71e-05	189	190	7	544d95df910f1b276995624509a7e41b219baca0
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 CTSC ITGAX ME3 THADA ZFYVE9 NUDC	1.71e-05	189	190	7	160963355256f7c0f2138da80c90de478f5a9fe8
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRABD2B KALRN KCNH3 SERPINI1 GUCY1A2 EGFLAM BAIAP3	1.71e-05	189	190	7	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 COL6A3 SLC9A9 COL6A5 GUCY1A2 TENM3 LRP1	1.71e-05	189	190	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD29 COL4A3 CTSC PTPN13 ATP8A1 C5 CACNA2D3	1.71e-05	189	190	7	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 LAMA1 DNER LRP1B ME3 ATP6V0A4 CACNA2D3	1.71e-05	189	190	7	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 LAMA1 DNER LRP1B ME3 ATP6V0A4 CACNA2D3	1.71e-05	189	190	7	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 LAMA1 DNER LRP1B ATP6V0A4 RPL11 CACNA2D3	1.71e-05	189	190	7	55420853f730b433ef58ac9337ac84ac78a247a0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 VWF MMP28 DOCK9 F8 TGM2 MMRN2	1.77e-05	190	190	7	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7 CATSPERB BAIAP3	2.42e-07	177	186	11	3395_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	HSPG2 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 CATSPERB BAIAP3	1.67e-06	173	186	10	4112_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A APAF1 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 CATSPERB BAIAP3	1.67e-06	173	186	10	5594_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CCDC28A APAF1 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7 CATSPERB BAIAP3	2.27e-06	179	186	10	5903_UP
Drug	AC1L1C2F	COL4A3 HSPG2 COL6A2 COL6A3 LAMA1 APOB RRAS PHYH	3.44e-06	110	186	8	CID000001711
Drug	vinylidene chloride	COL4A3 PLK2 ABCA1 TRABD2B CTSC APAF1 CPN1 RRAS DNAJC6 HPSE ITGAX PTGFR LYST PTGFRN LGALS3 ME3 TGM2 SAA1 FAT1 PTPN13 OXCT1 ALDH1L2 ATP6V0A4 LRP1 MTTP AK4 SLITRK6 NNT KNL1	9.56e-06	1475	186	29	ctd:C029297
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A_EA	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7 BAIAP3	1.14e-05	170	186	9	1014_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	CCDC28A APAF1 ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.25e-05	172	186	9	5580_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 ATP8A1 SLC17A7 BAIAP3	1.37e-05	174	186	9	5260_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.57e-05	177	186	9	6493_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.57e-05	177	186	9	3462_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 LYST CYP46A1 SERPINI1 ATP8A1 SLC17A7 BAIAP3	1.57e-05	177	186	9	5945_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.57e-05	177	186	9	1645_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A CHST1 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7	1.64e-05	178	186	9	6454_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	ASAP3 CHST1 DNAJC6 LYST CYP46A1 SERPINI1 ATP8A1 SLC17A7 BAIAP3	1.64e-05	178	186	9	4388_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A CHST1 DNAJC6 LYST CYP46A1 SERPINI1 ATP8A1 SLC17A7 BAIAP3	1.72e-05	179	186	9	2794_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A APAF1 ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.80e-05	180	186	9	5484_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.80e-05	180	186	9	6579_UP
Drug	2-(diethylamino)ethyl methacrylate	LAMA1 DNER F8	1.83e-05	7	186	3	CID000061012
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7 BAIAP3	1.88e-05	181	186	9	1471_UP
Drug	NSC-343257	HSPG2 ABCA1 DNER APOB HPSE LGALS3 NOMO1 TG SAA1 MTTP	1.92e-05	228	186	10	CID000004242
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7 BAIAP3	1.96e-05	182	186	9	7043_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CCDC28A DOCK9 DNAJC6 HPSE CYP46A1 PTPN13 SERPINI1 SYNJ1 SLC17A7	2.23e-05	185	186	9	6916_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 CATSPERB BAIAP3	2.43e-05	187	186	9	5976_UP
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; PC3; HT_HG-U133A	PADI4 ABCA1 ACADSB IAPP APOB SLCO1B1 SERPINI1 TENM3 SEZ6L	2.43e-05	187	186	9	4209_UP
Drug	2-propylpentanoic acid; Up 200; 10000uM; HL60; HG-U133A	NCOA3 HPSE OR10J1 MFN1 TGM2 VPS13D SERPINI1 SYNJ1 SEZ6L	2.76e-05	190	186	9	410_UP
Drug	NSC119914	CTSC SLCO1B1 DDC LGALS3	2.81e-05	22	186	4	CID000274126
Drug	2-propylpentanoic acid; Up 200; 1000uM; ssMCF7; HG-U133A	ASAP3 CHST1 CYP46A1 TGM2 SYNJ1 RRP12 SLC17A7 MTO1 BAIAP3	2.87e-05	191	186	9	497_UP
Drug	dansylhydrazine	VWF LYST NOMO1	2.92e-05	8	186	3	CID000094442
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A	COL4A3 PLK2 APAF1 ASAP3 CD1E ZFYVE9 CELSR3 SLC17A7 EDRF1	3.66e-05	197	186	9	3085_UP
Drug	prostacyclin sodium salt	GPI COL4A3 COL6A2 COL6A3 ABCA1 VWF CTSC APOB PTGFR ALOX12B	4.20e-05	250	186	10	CID000000159
Drug	DGM-2	LYST F8 TGM2	4.35e-05	9	186	3	CID000016891
Drug	tesaglitazar	HSPG2 IAPP APOB SAA1	5.60e-05	26	186	4	CID000208901
Drug	Anti-Retroviral Agents	VWF F8	6.64e-05	2	186	2	ctd:D044966
Drug	AC1L9REW	THADA NNT	6.64e-05	2	186	2	CID000454118
Drug	Tartronate	ME2 ME3	6.64e-05	2	186	2	DB03680
Drug	Uridine-Diphosphate-N-Acetylglucosamine	UAP1 GALE	6.64e-05	2	186	2	DB03397
Drug	Antihemophilic Factor	VWF PHYH LRP1	8.44e-05	11	186	3	DB00025
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	8.79e-05	172	186	8	5217_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	9.15e-05	173	186	8	5625_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	9.15e-05	173	186	8	5308_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	9.53e-05	174	186	8	6085_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	9.53e-05	174	186	8	5231_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 LYST CYP46A1 SERPINI1 SLC17A7 CATSPERB BAIAP3	9.92e-05	175	186	8	4153_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 TGM2 SERPINI1 SLC17A7	9.92e-05	175	186	8	2268_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	APAF1 ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.07e-04	177	186	8	4768_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 ASAP3 CHST1 DNAJC6 CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.07e-04	177	186	8	4770_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.07e-04	177	186	8	3312_UP
Drug	trichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.12e-04	178	186	8	873_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.16e-04	179	186	8	6551_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.21e-04	180	186	8	7236_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.25e-04	181	186	8	5987_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A APAF1 ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7	1.25e-04	181	186	8	6276_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.25e-04	181	186	8	1535_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.30e-04	182	186	8	6879_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.35e-04	183	186	8	6434_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TNFSF9 ASAP3 DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.40e-04	184	186	8	3643_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	CCDC28A ASAP3 LYST CYP46A1 SERPINI1 SLC17A7 CATSPERB BAIAP3	1.46e-04	185	186	8	5935_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	TNFSF9 CCDC28A DNAJC6 LYST CYP46A1 SERPINI1 SLC17A7 BAIAP3	1.51e-04	186	186	8	6891_UP
Drug	CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A	ABCA1 TNFSF9 ASAP3 DDO LYST TRIM22 SERPINI1 SLC17A7	1.51e-04	186	186	8	4380_UP
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY4 LYST WDFY3	9.66e-07	4	185	3	DOID:2935 (implicated_via_orthology)
Disease	Colorectal Carcinoma	ABCA1 KALRN LAMA1 ASAP3 APOB MFN1 TGM2 FAT1 SPACA7 CSE1L RPAP1 GUCY1A2 LRP1 MMRN2 KDM2A WDR49 EDRF1	2.32e-06	702	185	17	C0009402
Disease	Parkinson's disease (implicated_via_orthology)	GPI VPS13C RHOT2 DNAJC6 DDC SYNJ1 SLC17A8 SLC17A7	7.07e-06	157	185	8	DOID:14330 (implicated_via_orthology)
Disease	von Willebrand's disease 2 (is_marker_for)	VWF F8	3.91e-05	2	185	2	DOID:0060574 (is_marker_for)
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13C VPS13D	1.17e-04	3	185	2	DOID:0111611 (implicated_via_orthology)
Disease	Atypical juvenile parkinsonism	DNAJC6 SYNJ1	1.17e-04	3	185	2	C4510873
Disease	response to radiation, Urinary retention	COL6A3 PLK5 LRP1B	1.55e-04	17	185	3	GO_0009314, HP_0000016
Disease	Ullrich congenital muscular dystrophy	COL6A2 COL6A3	2.33e-04	4	185	2	cv:C4551860
Disease	Bethlem myopathy	COL6A2 COL6A3	2.33e-04	4	185	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A2 COL6A3	2.33e-04	4	185	2	C1834674
Disease	Ullrich congenital muscular dystrophy 1	COL6A2 COL6A3	2.33e-04	4	185	2	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A2 COL6A3	2.33e-04	4	185	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A2 COL6A3	2.33e-04	4	185	2	DOID:0050558 (is_implicated_in)
Disease	Malignant neoplasm of breast	GPI ANKRD29 NCOA3 VWF KALRN UBR4 DDO SLCO1B1 HPSE RNF115 SGK3 TGM2 GUCY1A2 TRAPPC12 ABRAXAS1 ADGRF4 PDZD4	4.53e-04	1074	185	17	C0006142
Disease	GlcNAc sulfate conjugate of C21H34O2 steroid measurement	SLCO1B1 ME2	5.77e-04	6	185	2	EFO_0800663
Disease	familial combined hyperlipidemia (is_marker_for)	VWF APOB	5.77e-04	6	185	2	DOID:13809 (is_marker_for)
Disease	epilepsy (implicated_via_orthology)	KALRN LRP1B RAB3C LRP1 ETNK1 NUDC	5.89e-04	163	185	6	DOID:1826 (implicated_via_orthology)
Disease	pneumococcal meningitis	ME2 ROS1	1.07e-03	8	185	2	EFO_1001114
Disease	hexadecenedioate (C16:1-DC) measurement	IAPP SLCO1B1	1.37e-03	9	185	2	EFO_0800562
Disease	lifestyle measurement, systolic blood pressure	SLC9A9 KALRN	1.37e-03	9	185	2	EFO_0006335, EFO_0010724
Disease	nicotine withdrawal symptom count	ANKRD29 UAP1 RNF180	1.37e-03	35	185	3	EFO_0009263
Disease	Tinnitus	APAF1 ITGAX PTPN13 WDR49 CACNA2D3	1.40e-03	130	185	5	HP_0000360
Disease	gout	ABCA1 PTGFRN MFN1 FAT1 NRXN2 CACNA2D3	1.53e-03	196	185	6	EFO_0004274
Disease	vesicular integral-membrane protein VIP36 measurement	GPI KALRN	1.70e-03	10	185	2	EFO_0022012
Disease	3-phenylpropionate hydrocinnamate measurement	LAMA1 RNF115	1.70e-03	10	185	2	EFO_0021010
Disease	familial hypercholesterolemia (is_implicated_in)	APOB MTTP	1.70e-03	10	185	2	DOID:13810 (is_implicated_in)
Disease	hepatocyte growth factor-like protein measurement	FBXW12 DNAH1 CELSR3	1.74e-03	38	185	3	EFO_0008154
Disease	serum IgG glycosylation measurement	SLC9A9 REC114 VPS13C DNER PTGFR LRP1B RAB3C TENM3 ALDH1L2 CSMD1	1.80e-03	523	185	10	EFO_0005193
Disease	Hypercholesterolemia	ABCA1 APOB MTTP	1.88e-03	39	185	3	C0020443
Disease	Inherited neuropathies	PHYH MTTP PRKCG	2.02e-03	40	185	3	C0598589
Disease	severe acute respiratory syndrome, COVID-19	COL6A3 CATSPERD USP9X WDFY4 LRP1B LYST TG CSMD1 CACNA2D3	2.14e-03	447	185	9	EFO_0000694, MONDO_0100096
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	APAF1 LRP1B TGM2 RIOK2 ALOX12B	2.46e-03	148	185	5	C0279702
Disease	Herpes Zoster, response to tofacitinib	VWF CACNA2D3	2.48e-03	12	185	2	EFO_0006510, EFO_0600024
Disease	vascular brain injury measurement, vascular brain injury	TRIL SEZ6L	2.91e-03	13	185	2	EFO_0006791, EFO_0006800
Disease	glycochenodeoxycholate glucuronide (1) measurement	IAPP SLCO1B1	2.91e-03	13	185	2	EFO_0800474
Disease	Hyperlipoproteinemia Type IIb	ABCA1 APOB	2.91e-03	13	185	2	C1704417
Disease	gallbladder cancer (is_implicated_in)	APOB LRP1B	2.91e-03	13	185	2	DOID:3121 (is_implicated_in)
Disease	albuminuria	COL4A3 RPAP1 CSMD1 ICA1L	2.94e-03	94	185	4	EFO_0004285
Disease	DNA methylation	ABCA1 CCDC30 FAM91A1 LRP1B RAB3C SLC35F4 THADA TENM3 CSMD1 DNAH6 CACNA2D3	2.99e-03	656	185	11	GO_0006306
Disease	response to statin, LDL cholesterol change measurement	APOB SLCO1B1	3.89e-03	15	185	2	EFO_0007804, GO_0036273
Disease	response to irinotecan	TRIL SYNE3	3.89e-03	15	185	2	EFO_0004829
Disease	malaria	PIGZ DDC CSMD1 NNT	3.94e-03	102	185	4	EFO_0001068
Disease	peak expiratory flow	DOCK9 ME3 THADA RPAP1 PKD1 LRP1 KDM2A NNT CACNA2D3	4.36e-03	498	185	9	EFO_0009718
Disease	Hyperlipoproteinemia Type IIa	ABCA1 APOB	4.43e-03	16	185	2	C0745103
Disease	focal segmental glomerulosclerosis	CCDC30 DNAH6	4.43e-03	16	185	2	EFO_0004236
Disease	Rolandic epilepsy	KALRN ALDH1L2	4.43e-03	16	185	2	Orphanet_1945
Disease	immature platelet count	VWF KALRN DDO AK4	4.52e-03	106	185	4	EFO_0803544
Disease	FEV/FEC ratio	HSPG2 COL6A3 REC114 VPS13C DOCK9 DNER SLCO1B1 ME3 TG SPTBN5 THADA RPAP1 DCAF17 LRP1 CSMD1 CACNA2D3	4.71e-03	1228	185	16	EFO_0004713
Disease	triglycerides in LDL measurement	ABCA1 APOB NUDC	5.27e-03	56	185	3	EFO_0022320
Disease	triglyceride measurement, intermediate density lipoprotein measurement	ABCA1 APOB MTTP NUDC	5.32e-03	111	185	4	EFO_0004530, EFO_0008595
Disease	Hypercholesterolemia, Familial	ABCA1 APOB	5.60e-03	18	185	2	C0020445
Disease	Unipolar Depression	KALRN APAF1 HPSE DDC TG LRP1	6.01e-03	259	185	6	C0041696
Disease	neuroblastoma	KALRN TRIM22 LGALS3 CSMD1	6.21e-03	116	185	4	EFO_0000621
Disease	acetone measurement	OXCT1 AK4	6.23e-03	19	185	2	EFO_0010989
Disease	familial hyperlipidemia (biomarker_via_orthology)	ABCA1 MTTP	6.23e-03	19	185	2	DOID:1168 (biomarker_via_orthology)
Disease	carotid artery disease (is_marker_for)	HSPG2 VWF	6.23e-03	19	185	2	DOID:3407 (is_marker_for)
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	VWF LGALS3	6.23e-03	19	185	2	DOID:9744 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IFVNGHFLQGSITFI	TMEM62	516	Q0P6H9
SGFVLGALAFQHLNT	ABRAXAS1	11	Q6UWZ7
SENFQEFLSLNGHLL	APAF1	541	O14727
FEVSSLENAFQIGGH	DCAF17	286	Q5H9S7
NSHELSTGFLNLAVF	ASAP3	91	Q8TDY4
FLSINLAGGHVEFRF	EGFLAM	661	Q63HQ2
GGNTFQLIANFHDDI	CATSPERB	436	Q9H7T0
QAEIIGSLGGIFHFF	CATSPERD	191	Q86XM0
GFQGQQSSEDLHVFY	CATSPERD	551	Q86XM0
QVLLKFHSDFSNGGF	CSMD1	2231	Q96PZ7
SNGGFFVLNFHAFQL	CSMD1	2241	Q96PZ7
HGFTNGSEFNLNDVV	CSMD1	2746	Q96PZ7
FSFLFVQGNQRAHGQ	COL4A3	1471	Q01955
LEALVSFFHAEGQGL	BAIAP3	951	O94812
ALIGQSLFGQEVYSH	ALDH1L2	26	Q3SY69
LNFYEGQITSFLGHN	ABCA1	921	O95477
LTFHIIFALLNAFQG	ADGRF4	631	Q8IZF3
AAQQGHNDVVRFLFG	ANKRD29	86	Q8N6D5
QFGKRLFDFQGLQHQ	ACADSB	321	P45954
QTLSHDGGFFNRLED	GKAP1	201	Q5VSY0
HLLNGVEFADSFNFN	DDC	286	P20711
LLHGYAFSQDENGIV	ATP8A1	1131	Q9Y2Q0
SQFNFAHSGFQLEDI	ASXL2	1086	Q76L83
SGHFFIFQGQTLLEG	REC114	71	Q7Z4M0
AGTLAAQLQETFGHF	RBM19	596	Q9Y4C8
AQLQETFGHFGSLGR	RBM19	601	Q9Y4C8
LSHAITLEFYQDGNG	NOMO3	596	P69849
THFAPGDFQGFALVN	HSPG2	1346	P98160
QLSFGNFAQLGHESF	HSPG2	1381	P98160
ERGQHLGEQLGFEFF	RAB3C	156	Q96E17
NHLIFRGGAQITFLA	ITGAX	866	P20702
RFDGTHSNFVLGNAQ	KCNH3	21	Q9ULD8
HSNFVLGNAQVAGLF	KCNH3	26	Q9ULD8
LAEGFHARLQEFQNF	MFN1	306	Q8IWA4
FQEQQNEGHGEALLF	PADI4	501	Q9UM07
LLLLFQHFGDSDGSQ	FAT1	11	Q14517
LSHAITLEFYQDGNG	NOMO2	596	Q5JPE7
HTNESNLAGFILLGF	OR2G2	6	Q8NGZ5
TDTGFLQTLGHNLFG	ITLN1	171	Q8WWA0
FIDRDGTHFGDVLNF	KCTD7	96	Q96MP8
GLRNTIALDFHFNQS	LRP1B	1286	Q9NZR2
AGLLHLGNIQFAASE	MYO19	301	Q96H55
FNDGEHSQGLKNDFV	EDRF1	291	Q3B7T1
FHSLFGNFQGLMEAN	MMRN2	751	Q9H8L6
THLVQRLFFAGQING	MTO1	421	Q9Y2Z2
AQNFGLQHLSSGHFL	AK4	26	P27144
TPNRIFFSDIHFGNI	LRP1	2251	Q07954
ALDFQRGNDVAFHFN	LGALS3	146	P17931
DIFLLGSRAFHNGLQ	EXD1	131	Q8NHP7
SLQVLNFVHSFQEGA	FAM91A1	766	Q658Y4
TDVHFNSLTGEGNFN	FER1L4	1536	A9Z1Z3
SFLQGQDSAIFDLGH	KRT80	116	Q6KB66
LNDFHSGKLQAFGNE	CCDC28A	186	Q8IWP9
FSITGFLLQRFEDHQ	FBXW12	366	Q6X9E4
TDFFGHLINGAIAVF	PTGFR	76	P43088
ASSGQHEGRVNLVFF	FAM157A	346	C9JC47
HFSQLGNSENFLLEV	LRRC36	146	Q1X8D7
GHEEGFLNNSGEFLF	MAPK6	656	Q16659
QTFNSDFILLGIFNH	OR2M2	6	Q96R28
STFNSDFILLGIFNH	OR2M3	6	Q8NG83
QTFNSDFILLGIFNH	OR2M5	6	A3KFT3
QTFNSDFLLLGIFNH	OR2M7	6	Q8NG81
LAEETHNFGLNFLQT	MTTP	231	P55157
GLQGDALQSRDFHFS	PDZD4	316	Q76G19
FIFDGLHQALLSVGV	EBLN2	131	Q6P2I7
GTFFDEIQQRHGLAN	KALRN	1391	O60229
SNFIGHLSGLVFNGQ	NRXN2	876	Q9P2S2
LSHAITLEFYQDGNG	NOMO1	596	Q15155
GILDIFGFENFEVNH	MYO10	431	Q9HD67
AFGDIFLHLLTGNLA	NELFB	456	Q8WX92
LDHLLQDDFFTQGFT	PLK5	56	Q496M5
SHVRDGLNFGTQIGF	LACC1	411	Q8IV20
NGKTGEFLAFQTVHL	KNL1	1591	Q8NG31
GLSIALHVGFDNFEQ	GPI	281	P06744
LHVGFDNFEQLLSGA	GPI	286	P06744
FGNVDSSGIKHNIFN	F8	2146	P00451
AAEIAIGLFFLHNQG	PRKCG	461	P05129
GTDGRVFHFLVFQLN	MRPL37	346	Q9BZE1
YNLTDNGLGHAFVQE	FBXL14	101	Q8N1E6
FINGSQLGEDFIQLH	HPSE	236	Q9Y251
ANFLVHSSNNFGAIL	IAPP	46	P10997
TFNHLFAIANSAEAG	DDO	71	Q99489
FVSEFHNFLSGLQLH	PLA2G4E	651	Q3MJ16
VIDNFHNAFRGGGSL	GALE	31	Q14376
IFGLHDNANITFAQN	DNAH1	3946	Q9P2D7
VGLTNHQLFFVGFAQ	EEF1AKMT4-ECE2	811	P0DPD8
LQLEGLFFTNGEHTS	APOB	3571	P04114
FHSFIQIVQASAGQF	CD1E	101	P15812
FFFPQGFLTGTLQNH	DNAH6	3991	Q9C0G6
DTLVFGGNFLHSFNI	KDM2A	291	Q9Y2K7
DSLVFGGNILHSFNV	KDM2B	321	Q8NHM5
LGADFRVHFGQIFNL	CC2D2A	701	Q9P2K1
IDVFSGHQNGSLRVF	C2CD3	936	Q4AC94
SFNFVLSANLHGGAV	CPN1	206	P15169
FFHLIQLGDGSYNLN	DOCK9	201	Q9BZ29
GLLDNFVTFFIAGHE	CYP46A1	291	Q9Y6A2
FNILSDFNHTGQGSI	CACNA2D3	346	Q8IZS8
NSHRLFLLVQAFGGV	DDX51	516	Q8N8A6
FDEFDSQAQHLLVLG	COL6A5	2541	A8TX70
NNANVFHLAGLTFLT	C5	641	P01031
FHLAGLTFLTNANAD	C5	646	P01031
VGENDFHFALVQFNG	COL6A3	71	P12111
FLLDGSERLGEQNFH	COL6A2	836	P12110
DFEDLLSGQGFNAHK	DNAJC6	781	O75061
DDLGNSGHFTIIYNQ	CTSC	76	P53634
LVNIGNHFDLASSIF	CBLN2	121	Q8IUK8
QEFAQLNHFTLGGKT	CCDC30	91	Q5VVM6
GAQQFSALTEVLFHF	COMMD7	26	Q86VX2
FIQHHGFNLFETAVL	LYST	436	Q99698
QLLNHFGRDFATGAV	ALOX12B	36	O75342
YGRNTLIQFEDFGNH	ME2	246	P23368
KLSNHVFVFQGAGEA	ME3	326	Q16798
DIGNHFNEFAGVSDV	ETNK1	341	Q9HBU6
HLLAFESHQQGFGLT	CELSR3	2236	Q9NYQ7
GFGLTATQDAHFNEN	CELSR3	2246	Q9NYQ7
QLFDLGFHVAGAFNN	ICA1L	401	Q8NDH6
LGNNHFIGFVNDSVT	DNER	276	Q8NFT8
LHNFIDGLAIGASFT	SLC39A14	346	Q15043
DFVNGGELFFHLQRE	SGK3	241	Q96BR1
HLQEVGLFHLGEFVN	DDB1	991	Q16531
LTFSGLHAEQAFVGQ	PKD1	3381	P98161
LSQSQVNGFFASHLG	PTPN13	1256	Q12923
QGFSSFHEQQITLFG	OR10J1	26	P30954
FILTHVDQLFGGAAL	ARHGAP30	206	Q7Z6I6
DFLHSANFSLGSINQ	RNF180	356	Q86T96
SLFVQNGFHVNEEFL	SERPINI1	111	Q99574
GIAHKFFGAENSVNL	PHYH	306	O14832
IRLTFFQGDHNDGLG	MMP28	181	Q9H239
LQDFFNGFDALLEHI	GUCY1A2	196	P33402
LAANHFGRFFTGQIT	NNT	206	Q13423
AVGGGFFLLQLANHT	FUNDC2	111	Q9BWH2
FLLQVHGSEDQDFGN	PTGFRN	776	Q9P2B2
LNGFQILHDRFINGS	USP9X	231	Q93008
GGSENYHELLENLQF	SPACA7	91	Q96KW9
TAVHFQDSGKLQGLF	THADA	816	Q6YHU6
FRTFQDDGLGTFQLH	SEZ6L	371	Q9BYH1
IEGILQHIFAGFFAN	RNF115	141	Q9Y4L5
QHIFAGFFANSAIPG	RNF115	146	Q9Y4L5
FQAHGSEGLTFQGLL	PLEKHN1	126	Q494U1
TFHGLENLEFLQADN	SLITRK6	131	Q9H5Y7
FQHQGAVELLVFNFL	SLC9A9	16	Q8IVB4
GLALFTFQNHIFNAL	SLC9A9	381	Q8IVB4
TFQNHIFNALFILGA	SLC9A9	386	Q8IVB4
GSHEDFSQLLRNFGQ	SYNE3	801	Q6ZMZ3
FNVRGTNDDGHVANF	SYNJ1	216	O43426
FEFLGINRQSISNFH	FNBP4	541	Q8N3X1
LLFFSHGQQNSAADL	GET4	71	Q7L5D6
AFLQAFLGRGLGHQD	RHOT2	431	Q8IXI1
IFNLELLDFNSAVGH	LAMA1	2651	P25391
HGFVSTHFLQREQNG	NCOA3	361	Q9Y6Q9
EALFFVGNQLIATSH	SHKBP1	291	Q8TBC3
GFAISGFNVNHLDIA	SLC17A7	416	Q9P2U7
EFNGQHFILEEAITG	OXCT1	191	P55809
QGLDFFPFLSGDNQH	PIAS1	541	O75925
EAAHFVSTLGFFNLI	SLC35F4	361	A4IF30
HEGGVQELVNTFFSF	NUDC	21	Q9Y266
QVLNLFFSALGGTSH	SLCO1B1	541	Q9Y6L6
HAFLRFGSNQEEALQ	RRP12	886	Q5JTH9
HNLAFAFLVAEQELG	SPTBN5	236	Q9NRC6
ENIQRFFGHGAEDSL	SAA1	81	P0DJI8
NHTYNELFVSGGFIV	TASOR	1316	Q9UK61
EGLVKALGVSNFNHF	AKR1B15	151	C9JRZ8
SGSSFVGQLFNQHLD	CHST1	71	O43916
YAFQVIGELHSQLDG	CLCA4	391	Q14CN2
QGSSFVLGHFILLFN	TGM2	126	P21980
FNGVDFEGTFHVNTQ	THBS4	776	P35443
LVLVNLHSGGQVFAF	TXNDC16	691	Q9P2K2
SQFQGNSQHDALEFL	USP43	176	Q70EL4
NRFQSGDFHVINGVL	CSE1L	136	P55060
GLTGFHTFLVALNQT	ZDHHC9	241	Q9Y397
FTQIFLRLQGGHFDL	WDFY3	2806	Q8IZQ1
FFDIHLFVNGTVTQG	VWF	91	P04275
DTGNFGFGIQEHIDL	RPL11	101	P62913
LGQNNFAEAHRFFTE	TRAPPC12	631	Q8WVT3
AFGAGHFLGNNTVID	TRABD2B	326	A6NFA1
LGGNFITNITAFDFH	TRIL	66	Q7L0X0
FDEAHGRLFISFNNQ	WDR49	116	Q8IV35
FLLQDIALEIFFHNG	WDFY4	2476	Q6ZS81
FDSNIDFQLVIGFHG	TENM3	2326	Q9P273
QESGVAFHNDSFQLG	VPS13C	1956	Q709C8
GFGNLVIFGSSSQLH	ROS1	541	P08922
TLNGFQILHDRFFNG	USP9Y	231	O00507
NGFLLFGVLHAQALQ	PIGZ	321	Q86VD9
EVDLLHFQSQFLAAG	RPAP1	11	Q9BWH6
NHGLIHGDFNEFNLI	RIOK2	221	Q9BVS4
AFGFQGRLLHLSAGQ	TNFSF9	196	P41273
LLFNAGNIANHFFTV	UAP1	321	Q16222
GEEFNFGDVFVHQAI	ATP6V0A4	711	Q9HBG4
ELGSQGGHFNQLVFT	ZNF566	131	Q969W8
SSGFGLEFNSFQHQL	TRIP4	406	Q15650
FGYQLSDHTVGVLFN	PLK2	516	Q9NYY3
LGHTFNAGIQQAFQL	ZBED1	291	O96006
GHGFLLVFAINDRQS	RRAS	101	P10301
FFEHNQQLTDVEFGG	UBR4	2291	Q5T4S7
QAQTSLDFLFHFGIP	VWA7	596	Q9Y334
NYGHGSLELLADVQF	TG	2616	P01266
AGIVSFFNVTNHGAL	TRIM22	451	Q8IYM9
GDHLLFASGDQVFQV	MST1R	506	Q04912
ALAGNVVSNLGHSFF	ZFYVE9	1006	O95405
FSGFAISGFNVNHLD	SLC17A8	426	Q8NDX2
HLGQIFIQNFVAGDD	VPS13D	1401	Q5THJ4
LSFGGLQFTENHLQF	KIAA2013	456	Q8IYS2